Prospective, Observational, Real-world Oral Malignant Tumors Study

CompletedOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Head and Neck NeoplasmsQuality of LifePostoperative Complications
Interventions
PROCEDURE

resection

This is an observational study. And we are interested in observing the outcome of different treatment methods.

RADIATION

adjuvant radiotherapy

This is an observational study. And we are interested in observing the outcome of different treatment methods.

DRUG

neoadjuvant chemotherapy or adjuvant chemotherapy

This is an observational study. And we are interested in observing the outcome of different treatment methods.

Trial Locations (7)

100038

Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing

100043

Department of Otolaryngology, Beijing Chaoyang Hospital, Capital Medical University, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Stomatological Hospital, Capital Medical University, Beijing

100081

School of Stomatology, Peking University, Beijing

200011

Department of Oral and Maxillofacial-Head & Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

450052

Department of Oral and Maxillofacial Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

Peking University Hospital of Stomatology

OTHER

collaborator

Beijing Shijitan Hospital, Capital Medical University

OTHER

collaborator

Beijing Friendship Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

UNKNOWN

collaborator

Beijing Chao Yang Hospital

OTHER

lead

Beijing Stomatological Hospital, Capital Medical University

OTHER

NCT02395367 - Prospective, Observational, Real-world Oral Malignant Tumors Study | Biotech Hunter | Biotech Hunter